376 patents currently held
666 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
3 more records may belong here and await a decision; they are not counted.
The next term ends in Nov 2026. from the record
Of the 666 now held by other companies, 286 name Vantive Health GmbH as their current owner, and 380 more name another party. Each row says which.
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
72
Ending by 2030
Nov 2026
Next term end
249
Patent families
When these terms end
Held patents by the year their term ends
notable patents
fee due within 90 days
all others
Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Notable: the highest-ranked patents in this portfolio by citations and family size. Fee due within 90 days: a maintenance fee is due within 90 days of when this page was computed and not yet paid.
Notable patents
Ranked by citations and family size, against patents of the same kind granted the same year. How we rank
Notable
Ends Jun 2027 · High confidence
Also notable
Ends Aug 2036 · High confidence
Also notable
Ends May 2040 · High confidence
System and Method for Identifying Data Streams Associated with Medical Equipment
US 7,698,156
The most cited patent in this portfolio, cited by 254 later US patents, top 5% of utility patents granted in 2010 in our data. Protection runs to 2027.
Medical Device Data Integration Apparatus and Methods
US 10,071,202
Cited by 70 later US patents, top 5% of utility patents granted in 2018 in our data, and renewed at every maintenance window due so far. Protection runs to 2036.
Medical Device Data Back-Association System, Apparatuses, and Methods
US 11,177,026
Cited by 55 later US patents, top 5% of utility patents granted in 2021 in our data. Protection runs to 2040.
Formerly held, still cited
Notable
Ends Jan 2027 · Medium confidence
The most cited patent in this portfolio, cited by 325 later US patents, top 1% of utility patents granted in 2011 in our data. Protection runs to 2027.
now held by Vantive Health GmbH
Also notable
Ends Dec 2036 · Medium confidence
Cited by 76 later US patents, top 5% of utility patents granted in 2021 in our data. Protection runs to 2036.
now held by Vantive Health GmbH
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 10 fees due Dec 2 to 20, 2026 · next Dec 2
- 8 fees due Jan 2 to 25, 2027 · next Jan 2
- 9 fees due Feb 1 to 28, 2027 · next Feb 1
- 7 fees due Mar 8 to 29, 2027 · next Mar 8
- 12 fees due Apr 1 to 29, 2027 · next Apr 1
- 3 fees due May 10 to 21, 2027 · next May 10
- 9 fees due Jun 5 to 29, 2027 · next Jun 5
- 2 fees due Jul 12 to 30, 2027 · next Jul 12
- 3 fees due Aug 2 to 16, 2027 · next Aug 2
- 3 fees due Sep 8 to 19, 2027 · next Sep 8
- 8 fees due Oct 2 to 28, 2027 · next Oct 2
- 4 fees due Nov 7 to 12, 2027 · next Nov 7
Recent changes
- Nov 3Assignment recorded on US 12,746,314: Baxter International Inc. to Vantive US Healthcare LLC Recorded Nov 3, 2026, executed Jul 23, 2025. Conveyance as recorded: Assignment of Assignor's Interest. A recorded assignment is a filed document, not a statement of current ownership. Reel 76617, frame 371.
- Sep 18Assignment recorded on 1 record: Baxter International Inc. to Vantive US Healthcare LLC Recorded Sep 18, 2026, executed Jul 23, 2025. Conveyance as recorded: Assignment of Assignor's Interest. A recorded assignment is a filed document, not a statement of current ownership. Reel 76064, frame 789.
- 35 of the patents on this record were granted since Aug 18, 2026
- 15 terms have ended since Aug 18, 2026
What they patent
The 5 largest of its 249 families, grouped by real patent family and labeled by the earliest filing in each. No technology classification is inferred from titles.
| Infusion System Using Optical Imager for Controlling Flow and Method Thereof | 10 in force | to Sep 2032 |
| Infusion Pump Door Seal for Vertical Intravenous Tubes | 8 in force | to Oct 2041 |
| Medical Device Data Integration Apparatus and Methods | 7 in force | to Aug 2036 |
| Method and System for Monitoring Hemodynamics | 6 in force | to Aug 2033 |
| Patch-Based Physiological Sensor | 5 in force | to Oct 2038 |
Patents held now
Soonest term end first.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,333,959 | Ex-Vivo Application of Solid Microparticulate Therapeutic Agents held by Baxter International Inc., Baxter Healthcare S.A. and Board of Regents of the University of Nebraska by and Behalf of the University of Nebraska Medical Center In force · Medium confidence | In force | Medium confidence | |
| US 7,762,795 | Rotary Axial Peristaltic Pumps and Related Methods held by Baxter International Inc. and Baxter Healthcare S.A. In force · High confidence | In force | High confidence | |
| US 7,537,174 | Hand Triggered Tissue Sealant Spray Apparatus and System held by Baxter International Inc. and Baxter Healthcare S.A. In force · High confidence | In force | High confidence | |
| US 11,896,939 | Device, System and Method for Mixing held by Baxter International Inc. and Baxter Healthcare S.A. In force · High confidence | In force | High confidence | |
| US 9,821,001 | Novel Aminoglycosides and Uses Thereof in the Treatment of Genetic Disorders held by Baxter International Inc. and Baxter Healthcare S.A. In force · Low confidence | In force | Low confidence | |
| US 8,703,122 | Method for Directed Cell In-Growth and Controlled Tissue Regeneration in Spinal Surgery held by Baxter International Inc. and Baxter Healthcare S.A. In force · High confidence | In force | High confidence | |
| US 8,834,864 | Methods for repairing and regenerating human dura mater held by Baxter International Inc. and Baxter Healthcare S.A. In force · High confidence | In force | High confidence | |
| US 8,722,736 | Multi-Dose Concentrate Esmolol with Benzyl Alcohol held by Baxter International Inc. and Baxter Healthcare S.A. In force · High confidence | In force | High confidence | |
| US 7,605,291 | Method for the Preparation of Volatile Anesthetics held by Baxter International Inc. and Baxter Healthcare S.A. In force · High confidence | In force | High confidence | |
| US 10,166,514 | Device, System and Method for Mixing held by Baxter International Inc. and Baxter Healthcare S.A. In force · High confidence | In force | High confidence |
Also on record, not counted in the 376: 666 patents in force now held by others · 697 patents ended · 213 applications pending · 511 applications abandoned · 6 records of undetermined status. List them
Sources and methods
Compiled from USPTO application file histories, grants and recorded assignments, with the company's own names reviewed by hand. How this record was built
Portfolio grouped automatically from ownership conveyances to the names matched to this company, usually every name that begins with its own, so it counts patents an affiliate holds; each list row names the holder of record. Security interests are excluded and ambiguous records are not reviewed by hand.
Fee due within 90 days marks a patent with a maintenance fee due within 90 days of the date this page was computed and not yet recorded paid, so it can end earlier than the bar shows. A fee left unpaid ends the patent at the close of the six month grace period that follows its due date, not on the due date itself. It is not a prediction that the fee will be missed.
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.